PREDICT-PD is a research project run by Queen Mary University London which aims to understand those most at risk of developing Parkinson’s Disease within the general population.
PREDICT-PD
Annual burden of Parkinson's Disease in the UK:

£300 million

77,000

172,000
Key Study Information:
-
Treatment Area:
Parkinson's Disease
-
Study Type:
Observational
-
Study Aim:
To identify people at high risk of Parkinson’s before the symptoms appear.
-
Recruitment Target:
5,000 patients without a diagnosis of PD
- Details of practice revenue available on request.
Speak to our study support specialist for more information on this study.

15 minutes to participate in this study
-
1
-
2
-
3
-
4
Step One
Practice - Choose a Study
Your practice can choose a study via our website or dedicated web application.

Step Two
Practice - Review & Approve Eligible Patients
uMed searches are compatible with EMIS or SystmOne. The results of this search are available to your practice in our web application for sign-off.

Step Three
uMed - Patient Contact
We provide a dedicated study support line for all patient enquiries to minimise incoming calls to your practice.
For most studies, between 10-30% of patients engage with our outreach.

Step Four
Patient - Consents to Join Study
Once the study concludes, we will share results and patient feedback with you so that you can see the impact of your participation. Any revenue generated from commercial studies is shared with your practice.

Not yet registered with uMed? Join over 400 GP Practices across the UK within the uMed Research Network and take part in the PREDICT-PD study. Join the uMed Research Network.
More about PREDICT-PD
PREDICT-PD is a ground-breaking project using simple tests to identify people at high risk of Parkinson’s disease before the symptoms appear.
Research suggests that problems including loss of sense of smell, sleep problems, constipation, anxiety and depression may occur many years before the movement problems of Parkinson’s appear.
Being able to predict who is going to get Parkinson’s before symptoms appear, provides huge potential for the development of treatments in the
early stages that could slow or prevent the condition progressing. This would be a major step forwards towards a cure and could have huge knock-
on implications for dementia and other age-related diseases of the brain.
Register your interest in this study
Fill in the below form and a member of our team will be in touch to discuss next steps to participate in this study.